LJUIF Stock Chart & Stats
$0.40
$0.00(0.00%)
At close: 4:00 PM EDT
$0.40
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.40 - $0.43
Previous CloseN/A
Volume7.00
Average Volume (3M)67.00
Market Cap
$995.66M
Enterprise Value$8.55K
Total Cash (Recent Filing)$1.82B
Total Debt (Recent Filing)$4.01B
Price to Earnings (P/E)15.4
Beta-0.07
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.53%
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,951,113,300
10 Day Avg. Volume0
30 Day Avg. Volume67
Financial Highlights & Ratios
PEG Ratio-0.32
Price to Book (P/B)1.14
Price to Sales (P/S)1.99
P/FCF Ratio27.69
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$0.44Price Target Upside9.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Manageable Leverage And Growing Asset BaseControlled leverage and a growing asset base provide financial resilience and flexibility. The company appears less exposed to balance-sheet stress, giving it capacity to sustain operations and fund development despite weaker recent profitability.
Positive Operating And Free Cash FlowPositive operating cash flow and the return to positive free cash flow support ongoing business needs and investment. Although conversion varies, the 2025 recovery indicates the company can generate internally funded liquidity over the medium term.
Historically Strong Profitability ProfileThe multi-year record of strong gross and net margins indicates an underlying profitable operating model and potential earnings quality. This history provides a foundation for recovery if the company stabilizes the 2025 profitability reset.
Bears Say
Revenue ContractionRevenue contraction weakens the scale benefits of the business and can reduce resources available for product development, commercial expansion, and fixed-cost absorption. Continued weakness would make a return to prior earnings levels more difficult.
Material Margin CompressionThe sharp decline from previously stronger margins signals reduced operating efficiency or profitability pressure. Unless margins recover, lower earnings power could persist even if revenue stabilizes, limiting the company’s ability to compound profits.
Sharp Decline In Return On EquityThe steep ROE decline shows that the substantial equity base is currently producing much less profit. Persistently weaker returns could indicate lower capital efficiency and reduce the attractiveness of reinvesting in the business.
SSY Group News
LJUIF FAQ
What was SSY Group Limited’s price range in the past 12 months?
SSY Group Limited lowest stock price was $0.40 and its highest was $0.43 in the past 12 months.
What is SSY Group Limited’s market cap?
SSY Group Limited’s market cap is $995.66M.
When is SSY Group Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were SSY Group Limited’s earnings last quarter?
Currently, no data Available
Is SSY Group Limited overvalued?
According to Wall Street analysts SSY Group Limited’s price is currently Undervalued.
Does SSY Group Limited pay dividends?
SSY Group Limited pays a Semiannually dividend of $0.004 which represents an annual dividend yield of 2.53%. See more information on SSY Group Limited dividends here
What is SSY Group Limited’s EPS estimate?
SSY Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SSY Group Limited have?
SSY Group Limited has 2,951,113,300 shares outstanding.
What happened to SSY Group Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of SSY Group Limited?
Currently, no hedge funds are holding shares in LJUIF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
SSY Group Limited
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; food, beverages, and catering businesses; and production and sale of methylamine. It sells its products under the Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was founded in 1999 and is headquartered in Wan Chai, Hong Kong.
LJUIF Stock 12 Month Forecast
Average Price Target
$0.44
▲(9.69% Upside)
Technical Analysis
China Traditional Chinese Medicine Holdings Co
―
Wai Yuen Tong Medicine Holdings Limited
―
Dawnrays Pharmaceutical Holdings Ltd.
―
Pak Fah Yeow International Limited
―
China Shineway Pharmaceutical Group Limited
―
Ownership Overview
―
Insiders
2.29% Mutual Funds
― Other Institutional Investors
95.48% Public Companies and
Individual Investors